The nation of Zimbabwe has declined a major US healthcare agreement valued at $367m (£272m) over five years because of the United States' request for confidential biological samples.
This rejection became public after a official document dated December was leaked, which showed President Emmerson Mnangagwa felt the arrangement was "skewed".
A government representative later clarified that the US was seeking health data for research and profit but refused to share the benefits from any future treatments.
"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged continued dialogue to reach a agreement agreeable to both sides so the country's critical HIV treatment initiative can continue.
Broader Background
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a high court blocked a similar deal with the US after concerns were filed about the security of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government agreements to boost openness and responsibility.
Based on reports, Sixteen nations in Africa have to date signed similar health pacts, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Our nation was requested to share its biological resources and data for a long time, with no equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"Put simply, our country would provide the raw materials for medical research with no assurance that the final treatments would be available to our population if a new pandemic emerge."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting systems already set up via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage future global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its information, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage further discussions with our American counterparts on how subsequent collaboration could be designed in a manner that honours the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but urged that talks must proceed given that much of the country's Aids initiatives were funded by international support.
"In cases where specific concerns exist, including those involving data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," it added.
This impasse highlights the ongoing tensions between accepting crucial foreign assistance and safeguarding national sovereignty in an ever more interconnected world.